ReviewPharmacology & therapeutics2021
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.
Nan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewPharmacology & therapeutics2021
Nan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.